AbbVie ABBV is set to report fourth-quarter and full-year 2024 earnings on Jan. 31, before the opening bell. The Zacks ...
The pharma giant’s performance has been pretty impressive, with its earnings exceeding expectations in each of the trailing four quarters. It delivered a trailing four-quarter average earnings ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results